Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Genetics and ovarian cancer: Risks and reality
Ovarian cancer is challenging due to late-stage detection. Understanding genetic risk factors and family history can aid in ...